Stockscreener 앱 받기
10.58
1.14%
0.11
전일 마감가:
$10.47
열려 있는:
$10.5
하루 거래량:
93,731
Relative Volume:
0.06
시가총액:
$1.70B
수익:
$394.50M
순이익/손실:
$-2.63M
주가수익비율:
-529.00
EPS:
-0.02
순현금흐름:
$70.29M
1주 성능:
+7.40%
1개월 성능:
-4.51%
6개월 성능:
-22.48%
1년 성능:
-11.83%
1일 변동 폭
$10.40
$10.61
1주일 범위
$9.47
$11.62
52주 변동 폭
$8.635
$15.69
Certara Inc Stock (CERT) Company Profile
명칭
Certara Inc
전화
(415) 237-8272
주소
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
CERT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
10.57 | 1.76B | 394.50M | -2.63M | 70.29M | -0.02 |
|
VEEV
Veeva Systems Inc
|
275.88 | 46.10B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
61.85 | 10.54B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
61.44 | 12.48B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.50 | 8.05B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.65 | 6.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-03 | 재개 | Morgan Stanley | Equal-Weight |
| 2025-05-08 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-02-27 | 개시 | TD Cowen | Buy |
| 2024-09-27 | 업그레이드 | UBS | Neutral → Buy |
| 2024-04-10 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | 개시 | JMP Securities | Mkt Perform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | UBS | Neutral |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-08-10 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2023-04-03 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2022-12-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | 개시 | Berenberg | Buy |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-01 | 개시 | Piper Sandler | Overweight |
| 2022-01-11 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-08-05 | 재개 | Credit Suisse | Neutral |
| 2021-07-23 | 개시 | Robert W. Baird | Outperform |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-06 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-01-05 | 개시 | BofA Securities | Buy |
| 2021-01-05 | 개시 | Credit Suisse | Neutral |
| 2021-01-05 | 개시 | Jefferies | Hold |
| 2021-01-05 | 개시 | William Blair | Outperform |
모두보기
Certara Inc 주식(CERT)의 최신 뉴스
Certara, Inc. Reports Strong Q2 2025 Earnings Growth - TipRanks
Certara, Inc. Reports Strong Q2 2025 Growth - TipRanks
Here's Why It's Unlikely That Certara, Inc.'s (NASDAQ:CERT) CEO Will See A Pay Rise This Year - 富途牛牛
Can Traders Expect Breakout From Certara Inc. This WeekLow Capital High Return Stock Plans Reviewed - beatles.ru
Certara signals full year 8–10% revenue growth outlook as AI and QSP momentum builds - MSN
Certara, Inc. (NASDAQ:CERT) Q2 2025 Earnings Call Transcript - Insider Monkey
Certara, Inc.'s (NASDAQ:CERT) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Yahoo Finance
Certara, Inc. (CERT) Q2 Earnings Miss Estimates - MSN
Certara 2025 Q2 Earnings Narrows Losses, Reports 84.3% Reduction in Net Loss - AInvest
Navigator Holdings Ltd. shares fall 1.00% intraday after Certara, Inc. reports Q2 2025 earnings. - AInvest
Certara, Inc. (CERT): A Bull Case Theory - Insider Monkey
UBS Maintains Certara (CERT) Rating, Lowers Price Target to $15. - GuruFocus
Leerink Partners lowers Certara stock price target to $11.50 on valuation concerns By Investing.com - Investing.com South Africa
Leerink Partners lowers Certara stock price target to $11.50 on valuation concerns - Investing.com Nigeria
Certara Surges 15.58% Amid Volatile Intraday Action—What’s Fueling the Rally? - AInvest
UBS Adjusts Price Target on Certara to $15 From $17.50, Maintains Buy Rating - MarketScreener
Earnings call transcript: Certara misses Q2 2025 EPS forecast, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: Certara misses Q2 2025 EPS forecast, stock dips - Investing.com
Certara’s Mixed Signals: Hold Rating Amidst Growth Potential and Strategic Uncertainty - TipRanks
Certara's Q2 Results and Strategic Positioning Support Buy Rating with $16 Price Target - AInvest
Certara (CERT) Q2 Revenue Jumps 12% - AOL.com
Decoding Certara Inc (CERT): A Strategic SWOT Insight - GuruFocus
Certara's AI-Driven Biosimulation Platform: A Catalyst for Drug Development Transformation - AInvest
Certara's Q2 2025 Earnings: Strategic Resilience in a Shifting Biosimulation Landscape - AInvest
Certara's Q2 2025 Earnings Call: Contradictory Signals on Market Potential, Demand Dynamics, and Retention Rates - AInvest
Certara Grows In Q2 But Falls Short Of Analyst Estimates - Finimize
Certara Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Press Release: Certara Reports Second Quarter 2025 Financial Results - 富途牛牛
Certara Q2 2025 slides: 12% revenue growth despite swing to net loss By Investing.com - Investing.com South Africa
Certara Q2 adjusted EPS misses estimates - MarketScreener
Certara Q2 2025 slides: 12% revenue growth despite swing to net loss - Investing.com UK
CERT SEC FilingsCertara, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Visual analytics tools that track Certara Inc. performanceSwing Reversal Forecast Based on Patterns - Newser
Navigator Holdings Ltd. shares rise 1.84% intraday after Certara's Simcyp Simulator receives EMA qualification. - AInvest
The PBPK Revolution: How Certara's Simcyp Simulator is Reshaping Drug Development and Regulatory Acceptance - AInvest
Certara Simcyp Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling - MarketScreener
Certara Obtains European Medicines Agency Qualification for Biosimulation Software - MarketScreener
Breakthrough: Certara's Simcyp Becomes Only Software Qualified by EMA for Drug Interaction Studies - Stock Titan
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling - The Manila Times
Certara's Simcyp® Simulator Achieves EMA Qualification for Regulatory Submissions in the EU - Quiver Quantitative
Why is Certara Inc. stock attracting strong analyst attentionUnlock daily market insights for better trades - Jammu Links News
What institutional investors are buying Certara Inc. stockUnlock powerful portfolio optimization tools - Jammu Links News
What markets is Certara Inc. expanding into Is KREF stock a good long term investment optionExceptional profit potential - Jammu Links News
What are analysts’ price targets for Certara Inc. in the next 12 monthsBreakthrough financial growth - Jammu Links News
What is the risk reward ratio of investing in Certara Inc. stockNavigate market volatility with smart strategies - Jammu Links News
How strong is Certara Inc. company’s balance sheetFree Expert Stock Watchlist - Jammu Links News
What catalysts could drive Certara Inc. stock higher in 2025Dynamic growth stocks - Jammu Links News
What makes Certara Inc. stock price move sharplyBuild a portfolio that stands the test of time - Jammu Links News
Is Certara Inc. stock overvalued or undervaluedHigh-profit trading signals - Jammu Links News
What drives Certara Inc. stock priceBuild wealth steadily with smart stock selection - Jammu Links News
How many analysts rate Certara Inc. as a “Buy”Discover breakthrough trading strategies - Jammu Links News
Certara Inc (CERT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.30%
2.62%
자본화:
|
볼륨(24시간):